
Only Half of Adults Adherent to Antidementia Medication Regimens at 1 Year: New Meta-Analysis Results
Only half of adults prescribed antidementia drugs (ADD) remain on therapy after 1 year, according to a large-scale meta-analysis that pooled data from 68 real-world studies involving nearly 700,000 adults aged 50 years or older. The average 12-month …